Financial Zimmer Biomet Increases Share Repurchase Expectations — Up to $1 Billion by Year End byJosh SandbergMay 12, 2026
Recon Regulatory Top Stories Zimmer Biomet Receives FDA Clearance for Expanded Reverse Shoulder Systems byJosh SandbergApril 17, 2026
Recon Robotics Top Stories Zimmer Biomet Appoints Dr. Jonathan M. Vigdorchik as Chief Science, Technology and Medical Affairs Officer byJosh SandbergApril 7, 2026
Recon Zimmer Biomet to Release New Data, Highlight Key Innovations at American Academy of Orthopaedic Surgeons Annual Meeting byJosh SandbergFebruary 25, 2026
Financial Zimmer Biomet Announces Quarterly Dividend for First Quarter of 2026 byTim AllenFebruary 23, 2026
Financial Zimmer Biomet Announces Fourth Quarter and Full-Year 2025 Financial Results byTim AllenFebruary 10, 2026
Financial Zimmer Biomet Announces Quarterly Dividend for Fourth Quarter of 2025 byJosh SandbergDecember 17, 2025
